Pages that link to "Q40152183"
Jump to navigation
Jump to search
The following pages link to Neuropathological Studies of Schizophrenia: A Selective Review (Q40152183):
Displaying 50 items.
- Olfactory function in psychotic disorders: Insights from neuroimaging studies (Q28083868) (← links)
- Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia (Q28473742) (← links)
- Postnatal development of D 1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis (Q30445870) (← links)
- Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia (Q30480517) (← links)
- Positron emission tomography and magnetic resonance imaging: A review and a local circuit neurons hypo(dys)function hypothesis of schizophrenia (Q31111338) (← links)
- Functional brain imaging in the evaluation of psychiatric illness (Q33517336) (← links)
- Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder (Q33628457) (← links)
- Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond (Q34783420) (← links)
- Neuropsychiatric rehabilitation for persistent mental illness (Q35531500) (← links)
- Psychosis and positron tomography (Q36445693) (← links)
- The neuropathology of schizophrenia. A focus on the subcortex. (Q36765118) (← links)
- The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition (Q37317846) (← links)
- Simultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia (Q37323826) (← links)
- Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge (Q37605220) (← links)
- Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia (Q37663262) (← links)
- Nerve growth factor: basic studies and possible therapeutic applications (Q38115344) (← links)
- What are the similarities and differences between schizophrenia and schizophrenia-like psychosis of epilepsy? A neuropathological approach to the understanding of schizophrenia spectrum and epilepsy. (Q38186393) (← links)
- Neuropsychological and P300 abnormalities in schizophrenics and their relatives. (Q38567068) (← links)
- Retroviral-mediated gene transfer. Applications in neurobiology (Q39338569) (← links)
- Dopamine receptors and the dopamine hypothesis of schizophrenia (Q39471744) (← links)
- Differential diagnosis and diagnostic systems in schizophrenia. (Q39730729) (← links)
- Brain noradrenaline and schizophrenia (Q39750054) (← links)
- Neuroradsology in Psychiatry (Q40118112) (← links)
- Are mental diseases brain diseases? The contribution of neuropathology to understanding of schizophrenic psychoses (Q40424380) (← links)
- The human striatum in schizophrenia. I. Increase in overall relative striatal volume in schizophrenics (Q40903827) (← links)
- Prefrontal lobotomy and hypofrontality in patients with schizophrenia: an integration of the findings (Q41126251) (← links)
- Computed tomography (CT) findings in schizophrenia: Speculation on the meaning of it all (Q41530187) (← links)
- Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics (Q41536508) (← links)
- Pilot study of computerised differentiation of Huntington's disease, schizophrenic, and Parkinson's disease patients using the contingent negative variation (Q45290590) (← links)
- Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia (Q46899484) (← links)
- Third ventricle enlargement and reduced electrodermal responsiveness (Q48101149) (← links)
- Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. (Q48121459) (← links)
- Ventricular enlargement and neuropsychological testing in schizophrenia (Q48222137) (← links)
- Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients (Q48301302) (← links)
- The reduced neuropil hypothesis: a circuit based model of schizophrenia (Q48303124) (← links)
- A comprehensive study of chronic schizophrenic patients. II: Biological, neuropsychological, and clinical correlates of CT abnormality (Q48380724) (← links)
- Ventricular enlargement in young chronic schizophrenics (Q48408348) (← links)
- Cognitive abnormalities and schizophrenic symptoms. (Q48409373) (← links)
- Third ventricle enlargement and lower heart rate levels in a high-risk sample (Q48482886) (← links)
- Computed tomographic brain studies and treatment response in schizophrenia (Q48484524) (← links)
- Normal ventricles in chronic schizophrenics (Q48557377) (← links)
- The acute periventricular injury syndrome: a possible animal model for psychotic disease (Q48559821) (← links)
- Birthweight and obstetric complications in schizophrenic twins (Q48568530) (← links)
- Regional Metabolism in Microsmic Patients with Schizophrenia (Q48635499) (← links)
- Progression of cerebroventricular enlargement and the subtyping of schizophrenia (Q48660044) (← links)
- Three syndromes in schizophrenia: validity in young patients with recent onset of illness (Q50665541) (← links)
- Spatiotemporal memory and rate of forgetting in acute schizophrenics (Q52120676) (← links)
- Treatment resistant chronic psychopathology and CT scans in schizophrenia. (Q54408892) (← links)
- Medication and psychotherapy in the treatment of chronic schizophrenia (Q68090259) (← links)
- [Schizophrenia, cognition and neuroimaging] (Q83164698) (← links)